Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines

Sulfonylureas (SUs) are one of the commonly prescribed oral anti-hyperglycemic agents (AHA) in low- and middle-income countries (LMICs), either in combination with metformin therapy or alone. However, concern about cardiovascular safety has limited the use of SUs in the management of type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Viswanathan, Saboo, Banshi, Khader, Jabbar, Modi, Kirtikumar D, Jindal, Sushil, Wangnoo, Subhash Kumar, Amarnath, Sugumaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854230/
https://www.ncbi.nlm.nih.gov/pubmed/35185350
http://dx.doi.org/10.1177/11795514221074663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854230/
https://www.ncbi.nlm.nih.gov/pubmed/35185350
http://dx.doi.org/10.1177/11795514221074663

Ejemplares similares